Utah Medical Products Debt to Equity Ratio 2010-2023 | UTMD
Current and historical debt to equity ratio values for Utah Medical Products (UTMD) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Utah Medical Products debt/equity for the three months ending December 31, 2023 was 0.00.
| Utah Medical Products Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2023-12-31 | $0.01B | $0.13B | 0.06 |
| 2023-09-30 | $0.01B | $0.12B | 0.06 |
| 2023-06-30 | $0.01B | $0.12B | 0.07 |
| 2023-03-31 | $0.01B | $0.12B | 0.08 |
| 2022-12-31 | $0.01B | $0.11B | 0.08 |
| 2022-09-30 | $0.01B | $0.11B | 0.10 |
| 2022-06-30 | $0.01B | $0.11B | 0.08 |
| 2022-03-31 | $0.01B | $0.11B | 0.10 |
| 2021-12-31 | $0.01B | $0.11B | 0.08 |
| 2021-09-30 | $0.01B | $0.11B | 0.09 |
| 2021-06-30 | $0.01B | $0.11B | 0.09 |
| 2021-03-31 | $0.01B | $0.11B | 0.09 |
| 2020-12-31 | $0.01B | $0.10B | 0.09 |
| 2020-09-30 | $0.01B | $0.10B | 0.09 |
| 2020-06-30 | $0.01B | $0.10B | 0.09 |
| 2020-03-31 | $0.01B | $0.09B | 0.09 |
| 2019-12-31 | $0.01B | $0.10B | 0.09 |
| 2019-09-30 | $0.01B | $0.10B | 0.10 |
| 2019-06-30 | $0.01B | $0.09B | 0.10 |
| 2019-03-31 | $0.01B | $0.09B | 0.14 |
| 2018-12-31 | $0.01B | $0.09B | 0.12 |
| 2018-09-30 | $0.01B | $0.09B | 0.12 |
| 2018-06-30 | $0.01B | $0.08B | 0.16 |
| 2018-03-31 | $0.02B | $0.08B | 0.18 |
| 2017-12-31 | $0.02B | $0.08B | 0.19 |
| 2017-09-30 | $0.01B | $0.08B | 0.12 |
| 2017-06-30 | $0.01B | $0.08B | 0.11 |
| 2017-03-31 | $0.01B | $0.07B | 0.13 |
| 2016-12-31 | $0.01B | $0.07B | 0.10 |
| 2016-09-30 | $0.01B | $0.07B | 0.14 |
| 2016-06-30 | $0.01B | $0.07B | 0.14 |
| 2016-03-31 | $0.01B | $0.07B | 0.16 |
| 2015-12-31 | $0.01B | $0.07B | 0.14 |
| 2015-09-30 | $0.01B | $0.07B | 0.17 |
| 2015-06-30 | $0.01B | $0.07B | 0.17 |
| 2015-03-31 | $0.01B | $0.06B | 0.18 |
| 2014-12-31 | $0.02B | $0.07B | 0.26 |
| 2014-09-30 | $0.02B | $0.06B | 0.28 |
| 2014-06-30 | $0.02B | $0.07B | 0.30 |
| 2014-03-31 | $0.02B | $0.06B | 0.32 |
| 2013-12-31 | $0.02B | $0.06B | 0.33 |
| 2013-09-30 | $0.02B | $0.06B | 0.41 |
| 2013-06-30 | $0.02B | $0.05B | 0.45 |
| 2013-03-31 | $0.03B | $0.05B | 0.51 |
| 2012-12-31 | $0.03B | $0.05B | 0.51 |
| 2012-09-30 | $0.03B | $0.05B | 0.62 |
| 2012-06-30 | $0.03B | $0.05B | 0.69 |
| 2012-03-31 | $0.04B | $0.05B | 0.80 |
| 2011-12-31 | $0.04B | $0.04B | 0.87 |
| 2011-09-30 | $0.04B | $0.04B | 0.96 |
| 2011-06-30 | $0.04B | $0.04B | 1.02 |
| 2011-03-31 | $0.04B | $0.04B | 1.13 |
| 2010-12-31 | $0.00B | $0.04B | 0.09 |
| 2010-09-30 | $0.00B | $0.04B | 0.11 |
| 2010-06-30 | $0.00B | $0.04B | 0.11 |
| 2010-03-31 | $0.01B | $0.04B | 0.13 |
| 2009-12-31 | $0.00B | $0.04B | 0.10 |
| 2009-09-30 | $0.01B | $0.04B | 0.13 |
| 2009-06-30 | $0.00B | $0.04B | 0.12 |
| 2009-03-31 | $0.01B | $0.04B | 0.15 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.249B | $0.050B |
| Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $183.775B | 24.06 |
| Stryker (SYK) | United States | $123.999B | 29.70 |
| Medtronic (MDT) | Ireland | $108.563B | 15.37 |
| Boston Scientific (BSX) | United States | $106.438B | 33.90 |
| EssilorLuxottica (ESLOY) | France | $97.377B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.685B | 0.00 |
| Haleon (HLN) | United Kingdom | $37.625B | 27.47 |
| ResMed (RMD) | United States | $31.870B | 29.92 |
| Terumo (TRUMY) | Japan | $26.117B | 36.88 |
| Koninklijke Philips (PHG) | Netherlands | $24.962B | 19.34 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.803B | 15.84 |
| Baxter (BAX) | United States | $18.605B | 13.23 |
| Insulet (PODD) | United States | $12.352B | 64.85 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.820B | 0.00 |
| Demant (WILYY) | Denmark | $10.525B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.041B | 23.96 |
| BellRing Brands (BRBR) | United States | $7.489B | 35.08 |
| Lantheus Holdings (LNTH) | United States | $5.234B | 13.04 |
| Haemonetics (HAE) | United States | $4.844B | 24.77 |
| Perrigo (PRGO) | Ireland | $4.530B | 12.96 |
| GN Store Nord (GNNDY) | Denmark | $4.368B | 24.53 |
| Prestige Consumer Healthcare (PBH) | United States | $3.475B | 16.43 |
| Envista Holdings (NVST) | United States | $3.276B | 13.52 |
| QuidelOrtho (QDEL) | United States | $2.903B | 10.54 |
| Green Thumb Industries (GTBIF) | United States | $2.634B | 83.47 |
| Neogen (NEOG) | United States | $2.630B | 25.29 |
| TG Therapeutics (TGTX) | United States | $2.552B | 71.78 |
| ICU Medical (ICUI) | United States | $2.454B | 18.31 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.265B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.886B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.786B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.683B | 49.34 |
| InMode (INMD) | Israel | $1.566B | 8.33 |
| Owens & Minor (OMI) | United States | $1.470B | 12.81 |
| National Vision Holdings (EYE) | United States | $1.431B | 44.56 |
| AdaptHealth (AHCO) | United States | $1.409B | 10.60 |
| Warby Parker (WRBY) | United States | $1.268B | 0.00 |
| AtriCure (ATRC) | United States | $1.052B | 0.00 |
| MacroGenics (MGNX) | United States | $1.024B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.985B | 0.00 |
| Evolus (EOLS) | United States | $0.838B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.822B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.726B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.666B | 14.43 |
| Quanterix (QTRX) | United States | $0.643B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.639B | 15.03 |
| Jin Medical (ZJYL) | China | $0.560B | 0.00 |
| Valneva SE (VALN) | France | $0.522B | 0.00 |
| PetIQ (PETQ) | United States | $0.519B | 19.40 |
| TerrAscend (TSNDF) | Canada | $0.501B | 0.00 |
| Surmodics (SRDX) | United States | $0.463B | 29.00 |
| Biote (BTMD) | United States | $0.452B | 4.30 |
| ZimVie (ZIMV) | United States | $0.431B | 26.37 |
| OraSure Technologies (OSUR) | United States | $0.421B | 6.96 |
| Aurora Cannabis (ACB) | Canada | $0.362B | 0.00 |
| Zynex (ZYXI) | United States | $0.341B | 46.70 |
| Cerus (CERS) | United States | $0.331B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.319B | 31.61 |
| Sanara MedTech (SMTI) | United States | $0.281B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.257B | 0.00 |
| Veru (VERU) | United States | $0.240B | 0.00 |
| Omeros (OMER) | United States | $0.213B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.202B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.194B | 0.00 |
| High Tide (HITI) | Canada | $0.176B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.174B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.167B | 0.00 |
| InterCure (INCR) | Israel | $0.165B | 27.85 |
| Eagleford Energy (GRUSF) | United States | $0.141B | 71.00 |
| Jushi Holdings (JUSHF) | United States | $0.138B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.127B | 20.44 |
| Cellectar Biosciences (CLRB) | United States | $0.119B | 0.00 |
| Fonar (FONR) | United States | $0.111B | 9.57 |
| MariMed (MRMD) | United States | $0.109B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.103B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.101B | 0.00 |
| Brainsway (BWAY) | Israel | $0.096B | 0.00 |
| Chimerix (CMRX) | United States | $0.090B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.067B | 0.00 |
| Safety Shot (SHOT) | United States | $0.065B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.059B | 3.87 |
| Cytosorbents (CTSO) | United States | $0.051B | 0.00 |
| Apyx Medical (APYX) | United States | $0.049B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.047B | 0.00 |
| ImmuCell (ICCC) | United States | $0.040B | 0.00 |
| Bright Green (BGXX) | United States | $0.039B | 0.00 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.50 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.020B | 0.00 |
| Flora Growth (FLGC) | United States | $0.020B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 72.73 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.007B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |